Non-Fc receptor-binding humanized anti-CD3 antibodies induce apoptosis of activated human T cells

Journal of Immunology

Volumn 165, Issue 11, 2000, Pages 6205-6213

  Carpenter, P A ^a   Pavlovic, S ^a   Tso, J Y ^a   Press, O W ^a   Gooley, T ^a   Yu, X Z ^a   Anasetti, C ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; FC RECEPTOR;

ALLOGRAFT; APOPTOSIS; ARTICLE; CELL DEATH; COMPLEX FORMATION; CROSS LINKING; CYTOKINE RELEASE; ENZYME PHOSPHORYLATION; GENETIC COMPLEMENTATION; HUMAN; HUMAN CELL; IMMUNOGENICITY; PRIORITY JOURNAL; RECEPTOR BINDING; T LYMPHOCYTE ACTIVATION;

EID: 0034547959     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.11.6205     Document Type: Article

References (73)

1. A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants
2. A humanized monovalent CD3 antibody which can activate homologous complement
3. Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3γ1(Ala-Ala) in the treatment of acute renal allograft rejection
4. Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER-2 protooncogene
5. HUM291, a humanized anti-CD3 antibody, is immunosuppressive to T cells while exhibiting reduced mitogenicity in vitro
6. The effect of aglycosylation on the immunogenicity of a humanized therapeutic CD3 monoclonal antibody
7. Human IgG2 variants of chimeric anti-CD3 are non-mitogenic to T cells
8. An anti-murine CD3 monoclonal antibody with a low affinity for Fc γ receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity
9. Partial TCR signals delivered by FcR-nonbinding anti-CD3 monoclonal antibodies differentially regulate individual Th subsets
10. Systemic reaction to the anti-T cell mAb OKT3 in relation to serum levels of tumor necrosis factor and interferon-γ
11. Fe receptors on monocytes cause OKT3-treated lymphocytes to internalize T3 and to secrete IL-2
12. Analysis of the monocyte Fe receptors and Ab-mediated cellular interactions required for the induction of T cell proliferation by anti-T3 Abs
13. Induction of apoptosis by anti-CD3εF(ab')2 in Ag receptor transgenic murine T cells activated by specific peptide
14. Treatment of acute graft-vs-host disease with a non-mitogenic anti-CD3 mAb
15. 2 fragments inhibit T cell expansion in vivo during graft-vs-host disease or the primary immune response to nominal
16. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: Distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation
17. T cell inactivation and cytokine deviation promoted by anti-CD3 mAbs
18. Induction of specific non-responsiveness in unprimed human T cells by anti-CD3 Ab and alloantigen
19. Induction of T cell unresponsiveness by anti-CD3 Abs occurs independently of co-stimulatory functions
20. 2 fragments of anti-CD3 mAb: F(ab')2 fragments induce a selective T helper dysfunction
21. T cell depletion in high Ag dose therapy of autoimmune encephalomyelitis
22. IL-2 programs mouse αβ T lymphocytes for apoptosis
23. Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells
24. Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle
25. Activation-induced T cell death is cell cycle dependent and regulated by cyclin B
26. 1 phase cell cycle check point
27. Cell cycle control of apoptosis in human leukemic T cells
28. Role of mitogen-activated protein kinases in activation-induced apoptosis of T cells
29. Induction of apoptosis in mature T cells by TNF
30. Die and let live: Eliminating dangerous lymphocytes
31. Mature lymphocyte apoptosis-Immune regulation in a dynamic and unpredictable antigenic environment
32. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance
33. 2
34. Serial triggering of many TCRs by a few peptide-MHC complexes
35. Differential TCR signaling regulates apoptosis and immunopathology during Ag responses in vivo
36. At grips with interactions
37. An unusual mechanism for ligand antagonism
38. + CTL clones is determined by the frequency of serial TCR engagement
39. Fidelity of T cell activation through multistep TCR ζ phosphorylation
40. Translating affinity into response
41. Partial T cell signaling: Altered phospho-ζ and lack of Zap70 recruitment in APL-induced T cell anergy
42. Autocrine feedback death and the regulation of mature T lymphocyte Ag responses
43. Selective induction of apoptosis in mature T lymphocytes by variant TCR ligands
44. Endocytosis and recycling of the T3-TCR complex: The role of phosphorylation
45. + T cells
46. Non-mitogenic anti-CD3 mAbs deliver a partial TCR signal and induce clonal anergy
47. T cell activation determined by TCR number and tunable thresholds
48. The duration of antigenic stimulation determines the fate of naive and effector T cells
49. Ikaros sets thresholds for T cell activation and regulates chromosome propagation
50. TCR signaling thresholds regulating T cell development and activation are dependent upon SHP-1
51. Formation of a bispecific Ab by the use of leucine zippers
52. 2 targeted to the human IL-2 receptor
53. Morphological, biochemical, and flow cytometric assays of apoptosis
54. Protein and cell-membrane iodination with a sparing soluble chloramide. 1,3,4,6-tetrachloro-3α,6α-diphenyl-glycouril
55. Endocytosis and degradation of murine anti-human CD3 mAbs by normal and malignant T-lymphocytes
56. Endocytosis and degradation of mAbs by normal and malignant T-lymphocytes
57. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl
58. A novel assay for apoptosis: Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled annexin V
59. The extracellular signal-regulated kinase pathway is required for activation-induced cell death of T cells
60. + T cells
61. Degradation of TCR (TCR)-CD3-ζ complexes after antigenic stimulation
62. Quantification of apoptosis in lymphocyte subsets and effect of apoptosis on apparent expression of membrane Ags
63. 2 fragments: Retention of the immunosuppressive properties of whole Ab with marked reduction in T cell activation and lymphokine release
64. Autocrine T cell suicide mediated by APO-1
65. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/ APO-1) death-inducing signaling complex
66. Molecular ordering of the Fas-apoptotic pathway: The Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-Ike cysteine proteases
67. Maintenance of clonotype specificity in CD95/Apo-1/Fas-mediated apoptosis of mature T lymphocytes
68. TCR signals enhance susceptibility to Fas-mediated apoptosis
69. TCR/CD3 coupling to Fas-based cytotoxicity
70. The phosphorylation state of CD37 influences T cell responsiveness and controls TCR cycling
71. Isotype choice for chimeric Abs affects binding properties
72. Ab framework residues affecting the conformation of the hypervariable loops
73. Conformational correction mechanisms aiding Ag recognition by a humanized Ab